Carret Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Carret Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.05M	Sell	8,246 -160	-2%	-$86.8K	0.4%	64
2025 Q4	$4.87M	Sell	8,406 -126	-1%	-$71.3K	0.46%	58
2025 Q3	$4.14M	Sell	8,532 -28	-0.3%	-$13K	0.4%	63
2025 Q2	$3.47M	Buy	8,560 +540	+7%	+$226K	0.37%	70
2025 Q1	$3.99M	Sell	8,020 -38	-0.5%	-$20.6K	0.45%	62
2024 Q4	$4.19M	Buy	8,058 +93	+1%	+$51.1K	0.46%	55
2024 Q3	$4.93M	Buy	7,965 +178	+2%	+$105K	0.53%	54
2024 Q2	$4.31M	Sell	7,787 -20	-0.3%	-$11.5K	0.5%	57
2024 Q1	$4.54M	Sell	7,807 -35	-0.4%	-$19.6K	0.53%	54
2023 Q4	$4.16M	Sell	7,842 -134	-2%	-$64.9K	0.53%	54
2023 Q3	$4.04M	Hold	7,976	–	–	0.56%	51
2023 Q2	$4.16M	Sell	7,976 -85	-1%	-$45.9K	0.55%	51
2023 Q1	$4.65M	Sell	8,061 -110	-1%	-$62K	0.65%	46
2022 Q4	$4.5M	Sell	8,171 -110	-1%	-$58.3K	0.62%	50
2022 Q3	$4.2M	Sell	8,281 -18	-0.2%	-$10.1K	0.63%	49
2022 Q2	$4.51M	Sell	8,299 -830	-9%	-$457K	0.63%	51
2022 Q1	$5.39M	Sell	9,129 -14	-0.2%	-$8.04K	0.62%	48
2021 Q4	$6.1M	Sell	9,143 -247	-3%	-$154K	0.68%	43
2021 Q3	$5.37M	Sell	9,390 -443	-5%	-$243K	0.64%	48
2021 Q2	$4.96M	Sell	9,833 -627	-6%	-$296K	0.58%	55
2021 Q1	$4.77M	Sell	10,460 -118	-1%	-$56.3K	0.59%	55
2020 Q4	$4.93M	Sell	10,578 -68	-0.6%	-$31.9K	0.66%	47
2020 Q3	$4.7M	Sell	10,646 -235	-2%	-$97.1K	0.71%	42
2020 Q2	$3.94M	Sell	10,881 -10	-0.1%	-$3.35K	0.64%	48
2020 Q1	$3.09M	Sell	10,891 -935	-8%	-$295K	0.59%	54
2019 Q4	$3.84M	Sell	11,826 -350	-3%	-$106K	0.56%	58
2019 Q3	$3.55M	Sell	12,176 -100	-0.8%	-$28.6K	0.56%	57
2019 Q2	$3.6M	Sell	12,276 -88	-0.7%	-$24.2K	0.57%	56
2019 Q1	$3.38M	Sell	12,364 -583	-5%	-$145K	0.55%	59
2018 Q4	$2.9M	Sell	12,947 -85	-0.7%	-$19.9K	0.52%	59
2018 Q3	$3.18M	Sell	13,032 -145	-1%	-$33.4K	0.49%	65
2018 Q2	$2.73M	Sell	13,177 -215	-2%	-$45.6K	0.45%	68
2018 Q1	$2.77M	Sell	13,392 -151	-1%	-$31.7K	0.45%	70
2017 Q4	$2.57M	Buy	13,543 +175	+1%	+$33.5K	0.4%	74
2017 Q3	$2.53M	Sell	13,368 -460	-3%	-$83.3K	0.41%	68
2017 Q2	$2.41M	Buy	13,828 +1,096	+9%	+$184K	0.41%	72
2017 Q1	$1.96M	Buy	12,732 +60	+0.5%	+$9.17K	0.35%	78
2016 Q4	$1.79M	Buy	12,672 +730	+6%	+$108K	0.34%	80
2016 Q3	$1.9M	Sell	11,942 -180	-1%	-$27.7K	0.36%	75
2016 Q2	$1.79M	Buy	12,122 +426	+4%	+$62.9K	0.35%	77
2016 Q1	$1.66M	Sell	11,696 -48	-0.4%	-$6.43K	0.35%	77
2015 Q4	$1.67M	Buy	11,744 +303	+3%	+$40.4K	0.36%	79
2015 Q3	$1.4M	Buy	11,441 +120	+1%	+$15.6K	0.31%	89
2015 Q2	$1.47M	Sell	11,321 -119	-1%	-$15.5K	0.29%	95
2015 Q1	$1.54M	Sell	11,440 -215	-2%	-$27.7K	0.3%	95
2014 Q4	$1.46M	Sell	11,655 -300	-3%	-$36.5K	0.28%	95
2014 Q3	$1.46M	Sell	11,955 -600	-5%	-$73K	0.28%	90
2014 Q2	$1.48M	Buy	12,555 +150	+1%	+$17.7K	0.28%	91
2014 Q1	$1.49M	Buy	12,405 +175	+1%	+$20.8K	0.3%	85
2013 Q4	$1.36M	Sell	12,230 -3,730	-23%	-$371K	0.28%	93
2013 Q3	$1.47M	Sell	15,960 -4,450	-22%	-$402K	0.33%	78
2013 Q2	$1.73M	Buy	+20,410	New	+$1.7M	0.36%	72

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carret Asset Management's TMO Position: Q1 2026 in Review

Carret Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q1 2026, selling an estimated $86.8K and leaving 8,246 shares worth $4.05M. The position accounts for 0.4% of the portfolio, ranked #64.

Carret Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.1M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Carret Asset Management held 8,246 shares of Thermo Fisher Scientific worth $4.05M as of Q1 2026.
Carret Asset Management sold 160 Thermo Fisher Scientific shares in Q1 2026, an estimated $86.8K.
Thermo Fisher Scientific made up 0.4% of Carret Asset Management's portfolio in Q1 2026, its #64 holding.
Carret Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Carret Asset Management's Thermo Fisher Scientific position peaked at $6.1M in Q4 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.